Eprodisate disodium clinical trials
How each study uses eprodisate disodium is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2001 (1)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2008 | 1 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Bellus Health Inc. - a GSK company (2) · C.T. Development America, Inc. (1)
Studies
Open first, then newest update. How each study uses eprodisate disodium is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA AmyloidosisCompletedPhase 3C.T. Development America, Inc.NCT01215747Written as KIACTA (eprodisate disodium)
- A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II DiabetesCompletedPhase 2Bellus Health Inc. - a GSK companyNCT00675857Written as NC-503 (eprodisate disodium)
- Study of the Safety and Efficacy of NC-503 in Secondary (AA) AmyloidosisCompletedPhase 2/3Bellus Health Inc. - a GSK companyNCT00035334Written as NC-503 (Anti-amyloidotic (AA) Agent)
Codes
What other systems call eprodisate disodium · ClinicalTrials.gg INT015141
- UNII (FDA) 5X0D9H16IUEPRODISATE DISODIUMConfirmed FDA, Wikidata
- Wikidata Q27262981eprodisate disodiumConfirmed FDA, Wikidata
- NCI Thesaurus C65520Eprodisate DisodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 5X0D9H16IU | EPRODISATE DISODIUM | Confirmed FDA, Wikidata |
| Wikidata | Q27262981 | eprodisate disodium | Confirmed FDA, Wikidata |
| NCI Thesaurus | C65520 | Eprodisate Disodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.